Proximagen Group's IPO

Proximagen Group raised a round of funding on March 31, 2005. Investors include Public.

Proximagen Group (AIM: PRX) is a biotechnology company focused on the development and commercialization of therapeutics for diseases of the central nervous system and inflammation.…

Articles about Proximagen Group's IPO: